CANCER BIOMARKERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Biomarker Type
• Market Snapshot, By Cancer Type
• Market Snapshot, By Profiling Technology
• Market Snapshot, By End User
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Cancer Biomarkers Market, By Biomarker Type, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• CA 125
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• HER2
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• EGFR
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• CD20
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• BRAF
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Calcitonin
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

5. Global Cancer Biomarkers Market, By Cancer Type, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Breast Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Lung Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Prostate Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Kidney Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Liver Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Head & neck Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Non-small Cell Lung Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Other Cancers
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Cancer Biomarkers Market, By End User, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• OMICS Technology
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Imaging Technology
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Immunoassays
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Cytogenetics
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Cancer Biomarkers Market, By End User, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022 – 2033
• Segment Trends
• Hospitals
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Specialty Clinics
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Diagnostic Laboratories
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Academic & Research Institutes
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

8. Global Cancer Biomarkers Market, By Region, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2022–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Biomarker Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Profiling Technology, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• bioMérieux, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• INOVIQ     
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Bio-Rad Laboratories, Inc.   
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Abbott   
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Becton, Dickinson and Company
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Merck KGaA 
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• QIAGEN   
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Thermo Fisher Scientific Inc. 
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• CENTOGENE N.V. 
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• PerkinElmer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Siemens Healthineers  
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• F. Hoffmann-la Roche Ltd.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Invitae Corporation  
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Myriad Genetics  
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Guardant Health  
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Illumina
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• FOUNDATION MEDICINE, INC.  
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact